This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- It was the strength in the commodities that was able to propel the markets higher today, Jim Cramer told his Mad Money viewers Thursday. Today's spike in oil prices was even strong enough to embolden money managers to do some buying, Cramer continued, and that led to a much-needed relief rally.

Cramer credited both the Federal Reserve and China for today's 369-point rise in the Dow Jones Industrial Average, saying that comments from the Fed about being pragmatic on interest rates, coupled with a sense that the Chinese may be getting serious about jump-starting their economy, all helped send stocks higher.

But the real winner on the day was the 10% spike in crude oil prices, something that acted as a major stress reliever for those fixed-income traders dealing in nearly $200 billion of oil company bonds.

Must Read: Stocks Survive Bungee Jump but Technicals Continue to Deteriorate

Not all was rosy in the markets, however. Cramer said there's a growing sense among money managers that a major hedge fund might be about to blow up in the same vein as Long Term Capital in 1998. There was also some profit-taking in the airline stocks, along with unexpected weak earnings from Williams-Sonoma (WSM), which fell 7.7%, along with Tiffany (TIF) and Dollar General (DG).

Most encouraging, however, was that buyers returned once again at the end of the day, Cramer concluded, afraid that they might miss more positive news overnight.

China and the Biotechs

What does turmoil in the Chinese economy have to do with the earnings of biotechs and big pharma? On the surface, nothing. People will still need medications no matter what the economy is doing. But dig a little deeper into the mechanics of the stock market, Cramer said, and things aren't quite that simple.

If the Chinese economy is downshifting, that could lead to a worldwide recession, which would cause a flight to safety, Cramer explained. Investors would sell stocks and buy more bonds.

So while the profits of the biotechs wouldn't change, their stock prices would, as investors sell their risky stocks in favor of bonds or at least stocks with dividend protection. However, even big pharma names with dividends aren't immune. Many investors buy these stocks on margin hoping for quick gains. As the margin calls mount, shares head lower.

Big pharma also has other problems, Cramer continued, currency risk. As money flows out of weak economies into strong ones, like ours, the dollar will strengthen, making foreign profits decline.

Ultimately, that makes neither biotechs nor big pharma safe investments during a recession. There is a silver lining however, and that's when stock prices fall, acquisitions happen -- as they did recently for Receptos (RCPT) and Pharmacyclics (PCYC).

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
CHGG $7.58 0.33%
PLKI $55.61 -1.10%
AAPL $112.76 -0.14%
FB $90.90 1.30%
GOOG $629.09 -1.30%


Chart of I:DJI
DOW 16,614.08 -40.69 -0.24%
S&P 500 1,984.45 -3.21 -0.16%
NASDAQ 4,816.9260 +4.2180 0.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs